These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 278471)

  • 41. Action profile of cobalt(III)-insulin. A novel principle of protraction of potential use for basal insulin delivery.
    Kurtzhals P; Ribel U
    Diabetes; 1995 Dec; 44(12):1381-5. PubMed ID: 7589842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absorption of isophane (NPH) insulin and its clinical implications.
    Lauritzen T; Pramming S; Gale EA; Deckert T; Binder C
    Br Med J (Clin Res Ed); 1982 Jul; 285(6336):159-62. PubMed ID: 6807390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin binding and free insulin in serum of insulin-treated diabetics.
    Lev-Ran A; Ratt L
    Horm Metab Res; 1973 Mar; 5(2):67-70. PubMed ID: 4707702
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject.
    Ferrannini E; Linde B; Faber O
    Clin Physiol; 1982 Feb; 2(1):59-70. PubMed ID: 7049512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative evaluation of insulin antibodies by radiochemical analysis.
    Palumbo A; Castaldello L; D'Amico P; Riboldi G
    Clin Chim Acta; 1978 Jan; 82(1-2):25-30. PubMed ID: 618682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of an algorithm for the artificial B-cell using the normal insulin-glucose relationship in diabetic dogs and men.
    Fischer U; Jutzi E; Bombor H; Freyse EJ; Salzieder E; Albrecht G; Besch W; Bruns W
    Diabetologia; 1980; 18(2):97-107. PubMed ID: 6988280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum IRI in insulin-treated diabetics during a 24-hour period.
    Rasmussen SM; Heding LG; Parbst E; Volund A
    Diabetologia; 1975 Apr; 11(2):151-8. PubMed ID: 1149948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps.
    Finegood DT; Bergman RN; Vranic M
    Diabetes; 1988 Aug; 37(8):1025-34. PubMed ID: 3292323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extraction of plasma insulin in radioimmunoassay for removal of nonspecific inhibitor and of circulating insulin antibody.
    Oneda A; Toyota T; Sato S; Yamagata S
    Tohoku J Exp Med; 1970 Jan; 100(1):75-84. PubMed ID: 5461274
    [No Abstract]   [Full Text] [Related]  

  • 50. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics.
    Gennaro WD; Van Norman JD
    Clin Chem; 1975 Jun; 21(7):873-9. PubMed ID: 236845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat.
    Okumura K; Komada F; Hori R
    J Pharmacobiodyn; 1985 Jan; 8(1):25-32. PubMed ID: 3891962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.
    Koivisto VA; Felig P
    Ann Intern Med; 1980 Jan; 92(1):59-61. PubMed ID: 6444267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
    Heinemann L; Klappoth W; Rave K; Hompesch B; Linkeschowa R; Heise T
    Diabetes Care; 2000 Sep; 23(9):1343-7. PubMed ID: 10977030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraregional differences in the absorption of unmodified insulin from the abdominal wall.
    Frid A; Linde B
    Diabet Med; 1992 Apr; 9(3):236-9. PubMed ID: 1533580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats.
    Tokihiro K; Arima H; Tajiri S; Irie T; Hirayama F; Uekama K
    J Pharm Pharmacol; 2000 Aug; 52(8):911-7. PubMed ID: 11007061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The measurement of total plasma insulin and insulin antibody levels in diabetic children.
    Dunlop M; Court JM
    Clin Chim Acta; 1974 May; 52(3):353-9. PubMed ID: 4839095
    [No Abstract]   [Full Text] [Related]  

  • 58. Modeling Subcutaneous Absorption of Fast-Acting Insulin in Type 1 Diabetes.
    Schiavon M; Dalla Man C; Cobelli C
    IEEE Trans Biomed Eng; 2018 Sep; 65(9):2079-2086. PubMed ID: 29989928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of acid regular and neutral regular insulin. Reponses of normal fasted subjects to varying doses of regular insulin.
    Galloway JA; Root MA; Rathmacher RP; Carmichael RH
    Diabetes; 1973 Jun; 22(6):471-9. PubMed ID: 4713672
    [No Abstract]   [Full Text] [Related]  

  • 60. [Serum insulin radioimmunoassay using polyethylene glycol (PEG) method. Detection of insulin antibody by PEG precipitation and cellulose acetate membrane electrophoresis].
    Nogami S; Suzuki K; Nakashikiryo K; Ishizuka N; Kayanuma H; Ogasawara M; Kondo T; Fukushi M; Uchikawa T
    Kaku Igaku; 1983 Feb; 20(1):83-9. PubMed ID: 6348356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.